April 2008 - Innovation Dynamics' Chairman, Dr Kelvin Hopper, presented an overview of the Australian and New Zealand biotech scene at the "Excellence in Biotechnology Investment" conference on 21st April in Sydney. Despite restricted funding and low share prices, the potential for future investment in a number of companies is exceptionally good and the biotech sector is robust.

|